Larson Financial Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Larson Financial Group's DGX Position: Q2 2026 in Review
Larson Financial Group increased its Quest Diagnostics (DGX) stake by 11% in Q2 2026, buying an estimated $11K and bringing the position to 569 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #1082.
Larson Financial Group first reported a position in DGX in Q2 2020 and has held it in 25 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Larson Financial Group held 569 shares of Quest Diagnostics worth $121K as of Q2 2026.
- Larson Financial Group bought 56 Quest Diagnostics shares in Q2 2026, an estimated $11K.
- Quest Diagnostics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1082 holding.
- Larson Financial Group first reported a position in Quest Diagnostics in Q2 2020 and has held it in 25 quarters since.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.